This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mimouni, A.
Right arrow Articles by Shohat, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mimouni, A.
Right arrow Articles by Shohat, M.
Related Collections
Right arrow Genetics & Dysmorphology

PEDIATRICS Vol. 105 No. 5 May 2000, p. e70

ELECTRONIC ARTICLE:
Familial Mediterranean Fever: Effects of Genotype and Ethnicity on Inflammatory Attacks and Amyloidosis

Received Jun 29, 1999; accepted Dec 21, 1999.

Aviva Mimouni*, Nurit Magal*, Nava Stoffman*, Tamy Shohat*, Ara MinasianDagger , Michael Krasnov*, Gabrielle J. Halpern*, Jerome I. Rotter§, Nathan Fischel-Ghodsian§, Yehuda L. Danonparallel , and Mordechai Shohat*

From the * Department of Medical Genetics, FMRC and Beilinson Campus, Rabin Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel; Dagger  Emergency Medical Scientific Center, Yerevan, Armenia; § Medical Genetics Birth Defects Center, Cedars-Sinai Medical Center, and University of California, Los Angeles, California; and parallel  Department of Immunology, FMRC and Beilinson Campus, Rabin Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Objective.  The gene causing familial Mediterranean fever (FMF)---an autosomal recessive disease characterized by recurrent short episodes of fever associated most commonly with peritonitis, pleuritis, and arthritis---has recently been found and several mutations identified. The most severe complication of the disease is amyloidosis, which can lead to renal failure. The aim of this study was to investigate the role of genetic versus nongenetic factors on the phenotype as well as on the development of amyloidosis in FMF in a large and heterogeneous group of patients.

Methodology.  We studied 382 patients from 4 ethnic origins living in different environments: North African Jews, other Jews, Turks, Armenians living in the United States, and Armenians from Yerevan, Armenia. Information regarding amyloidosis was available for 371 patients. We examined the association between the mutation M694V and the development of amyloidosis, and we also compared the clinical characteristics of the inflammatory attacks in patients from different ethnic origins, while controlling for the type of mutation.

Results.  A significant association was found between amyloidosis and the most common mutation in exon 10 of the FMF gene (MEFV), M694V (for M694V homozygotes, relative risk = 1.77; 95% CI = 1.16-2.71). Amyloidosis was present in 44 of 171 homozygous FMF patients (25.7%), in 22 of 143 compound heterozygous FMF patients (15.4%), and in 7 of 57 patients carrying other mutations (12.3%). In homozygotes for M694V who had not been treated with colchicine before 20 years of age, the risk of amyloidosis developing before this age was 61.0%. In our series, there were no cases of amyloidosis in 16 patients carrying the common mutation E148Q. We found that the type and severity of the FMF inflammatory symptoms were associated with both the genotype and the country of residence of the patient.

Conclusions.  In the light of the high frequency of amyloidosis in homozygotes for the mutation M694V, colchicine treatment should be given to this group irrespective of the severity of the inflammatory attacks to prevent the development of amyloidosis. Our findings also suggest that factors other than genotype, such as environment or genes other than MEFV, play a role in the determination of the severity of the inflammatory attacks in FMF. amyloidosis, specific mutation, phenotype-genotype correlation, ethnicity. .